COMMUNIQUÉS West-GlobeNewswire

Valneva Announces the Launch of a Private Placement of Ordinary Shares for Approximately 60 Million Euros

12/09/2024 - 22:05

Saint-Herblain (France), September 12, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (“ Valneva ” or the “ Company ”), a specialty vaccine company, today announces its intention to issue, subject to market [...]

Valneva annonce le lancement d’un projet d’augmentation de capital d’environ 60 millions d’euros

12/09/2024 - 22:05

Saint-Herblain (France), 12 septembre 2024 – Valneva SE (Nasdaq : VALN ; Euronext Paris : VLA) ( « Valneva » ou la « Société » ), société spécialisée dans les vaccins, annonce aujourd’hui, sous réserve des conditions de [...]

Immunocore to present at the 2024 Cantor Global Healthcare Conference

12/09/2024 - 22:05

Immunocore to present at the 2024 Cantor Global Healthcare Conference (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 12 September 2024) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or [...]

Immuneering Announces Positive Initial Phase 2a Data Including Complete and Partial Responses with IMM-1-104 in Combination with Chemotherapy in First-Line Pancreatic Cancer Patients

12/09/2024 - 22:05

- In Phase 2a arm investigating IMM-1-104 in combination with modified gemcitabine/nab-paclitaxel, complete or partial responses have been observed in the first two patients (2/5) to date, for an initial response rate [...]

AVITA Medical to Present at 2024 Cantor Global Healthcare Conference

12/09/2024 - 22:05

VALENCIA, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin [...]

Cidara Therapeutics Restructures Workforce to Focus on Planned Clinical Development of CD388

12/09/2024 - 22:05

SAN DIEGO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to [...]

QIAGEN and Bio-Manguinhos/Fiocruz collaborate to enhance malaria and dengue detection in Brazil’s national screening programs

12/09/2024 - 22:05

Advanced PCR-based screening platform deployed nationwide across 30 laboratories provides new capabilities to detect malaria, HIV, HCV, and HBV in blood donations // Advanced capabilities support epidemiological [...]

Generation Bio to Present at the 2024 Cantor Global Healthcare Conference

12/09/2024 - 22:05

CAMBRIDGE, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff [...]

Tilray Brands Completes Acquisition of Atwater Brewery From Molson Coors Beverage Company

12/09/2024 - 22:05

NEW YORK, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”, “our”, “we” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company, has successfully completed the [...]

One of the Largest and Most Diverse Studies on Sickle Cell Trait and Blood Clots Reveals Findings That Impact All Populations

12/09/2024 - 22:05

23andMe, National Human Genome Research Institute, and Johns Hopkins University conducted collaborative research that studied sickle cell trait in a diverse population SUNNYVALE, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE [...]

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

12/09/2024 - 22:05

BEDFORD, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to improving vision in the real world through the development and [...]

NurExone Biologic Extends Global Reach with Presentations at Industry-Leading Conferences

12/09/2024 - 22:04

TORONTO and HAIFA, Israel, Sept. 12, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “ Company ” or “ NurExone ”), a biopharmaceutical company developing exosome-based [...]

Celldex Therapeutics to Present at Upcoming Investor Conferences

12/09/2024 - 22:01

HAMPTON, N.J., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in fireside chats at two upcoming conferences: 2024 Cantor Global Healthcare [...]

Fate Therapeutics to Present at 2024 Cantor Global Healthcare Conference

12/09/2024 - 22:01

SAN DIEGO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)- [...]

Cytek Announces Resignation of Chief Operating Officer Chris Williams

12/09/2024 - 21:20

FREMONT, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that its Chief Operating Officer, Chris Williams, will resign his [...]

High Haven Cannabis Celebrates the Grand Opening of Elgin Dispensary

12/09/2024 - 19:38

ELGIN, Ill., Sept. 12, 2024 (GLOBE NEWSWIRE) -- High Haven Cannabis is thrilled to announce the grand opening of its newest retail dispensary in Elgin, IL , on September 21st, 2024. The event, scheduled from 9:00 AM to [...]

BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions

12/09/2024 - 19:23

KUALA LUMPUR, Malaysia, Sept. 13, 2024 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC, the “Company”), an emerging biotechnology company focused on innovative healthcare solutions, is pleased to announce the [...]

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2024

12/09/2024 - 18:00

Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2024 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]

EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 août 2024

12/09/2024 - 18:00

Nombre total de droits de vote et d’actions composant le capital social au 31 août 2024 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Charenton- [...]